Amgen says FTC case to block Horizon Therapeutics deal `defies logic’ Finances August 23, 2023 [ad_1] JHVEPhoto/iStock Editorial by way of Getty Photos Amgen (NASDAQ:AMGN) mentioned that the Federal Commerce Fee’s lawsuit to problem its…
Amgen Repatha patent spat with Sanofi heard by Supreme Court Finances March 27, 2023 [ad_1] bloodua The U.S. Supreme Courtroom earlier Monday heard arguments in a patent case filed by Amgen (NASDAQ:AMGN) concerning its…
